Targeting IL-4 for the Treatment of Atopic Dermatitis

Atopic dermatitis (AD) is an immune-mediated inflammatory skin disease characterized by a predominant type 2 immune response. Type 2 immunity is driven by multiple cytokines, including interleukin (IL)‑4 and IL-13 that are considered central to AD pathogenesis and key therapeutic targets. The dual i...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiricozzi, Andrea, Maurelli, Martina, Peris, Ketty, Girolomoni, Giampiero
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532907/
https://www.ncbi.nlm.nih.gov/pubmed/33062619
http://dx.doi.org/10.2147/ITT.S260370

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532907/
https://www.ncbi.nlm.nih.gov/pubmed/33062619
http://dx.doi.org/10.2147/ITT.S260370

Ejemplares similares